Live Breaking News & Updates on Boehringer Ingelheim Fremont Inc

Stay updated with breaking news from Boehringer ingelheim fremont inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tackling Health Disparities and Inequities for Women with Heart Failure: New Program Encourages Black and Latina Women to Demand More From Their Care

Despite a similar prevalence of the chronic condition, women diagnosed with heart failure have worse outcomes compared to men. A deeper look reveals that among Black and Latina women with heart failure, negative health outcomes are magnified due to significant health disparities and inequities that exist in the . ....

Matt Caffrey , Alanna Morris , Eli Lilly , Anita Holz , Centers For Disease , Boehringer Ingelheim Animal Health , Boehringer Ingelheim Pharmaceuticals Inc , Emory University School Of Medicine , Boehringer Ingelheim , Division Of Cardiology , Lilly Alliance , Boehringer Ingelheim Corporation , Heart Health , Animal Health , Clinical Development , Boehringer Ingelheim Fremont Inc , Hear Your Heart , Heart Failure Reveal Gaps , Associate Professor , Emory University School , Disease Control , Executive Director , Therapeutic Area Head Cardiometabolism , Medical Affairs , Boehringer Ingelheim Pharmaceuticals , Associate Vice President ,

Tackling Health Disparities and Inequities for Women with Heart Failure: New Program Encourages Black and Latina Women to Demand More From Their Care

/PRNewswire/ Despite a similar prevalence of the chronic condition, women diagnosed with heart failure have worse outcomes compared to men. A deeper look. ....

United States , Stephan Thalen , Matt Caffrey , Alanna Morris , Eli Lilly , Jennifer Forsyth , Anita Holz , Global Business Communications , Boehringer Ingelheim Pharmaceuticals Inc , Emory University School Of Medicine , Boehringer Ingelheim , Division Of Cardiology , Boehringer Ingelheim Animal Health In Duluth , Clinical Development , Centers For Disease , Lilly Alliance , Boehringer Ingelheim Corporation , Heart Health , Animal Health , Boehringer Ingelheim Fremont Inc , Hear Your Heart , Heart Failure Reveal Gaps , Associate Professor , Emory University School , Disease Control , Executive Director ,

Jardiance® phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease

The Independent Data Monitoring Committee recommended that the EMPA-KIDNEY trial be stopped early, following a formal interim assessmentEMPA-KIDNE. ....

United Kingdom , Stephan Thalen , Richard Haynes , Colin Baigent , Anne Whitehouse , Martin Landray , Eli Lilly , William Herrington , Mohamed Eid , Jeff Emmick , Boehringer Ingelheim Pharmaceuticals Inc , Clinical Development Medical Affairs , Oxford Population Health , Boehringer Ingelheim , Research Council Population Health Unit , Population Health Research Unit , Boehringer Ingelheim Animal Health In Duluth , Product Development , Research Council , University Of Oxford , Steering Committee , Data Monitoring Committee , Exchange Commission , Boehringer Ingelheim Corporation , Animal Health , Boehringer Ingelheim Fremont Inc ,

Jardiance® provided a significant clinical benefit in adults stabilized in hospital following acute heart failure in EMPULSE phase III trial

/PRNewswire/ Adults hospitalized for acute heart failure were 36% more likely to experience a clinical benefit over 90 days if initiated on Jardiance®. ....

United States , Stephan Thalen , Adriaan Voors , Mohamed Eid , Jennifer Forsyth , Eli Lilly , Jeff Emmick , Global Business Communications , Boehringer Ingelheim Pharmaceuticals Inc , Clinical Development Medical Affairs , Boehringer Ingelheim , Boehringer Ingelheim Animal Health In Duluth , Product Development , American Heart Association Late , University Medical Center , Drug Administration , Exchange Commission , Boehringer Ingelheim Corporation , Animal Health , National Readmission Database , Boehringer Ingelheim Fremont Inc , Kansas City Cardiomyopathy Questionnaire , Nature Medicine , American Heart Association , Late Breaking Scientific Sessions , National Readmission ,

Jardiance® provided a significant clinical benefit in adults stabilized in hospital following acute heart failure in EMPULSE phase III trial

/PRNewswire/ Adults hospitalized for acute heart failure were 36% more likely to experience a clinical benefit over 90 days if initiated on Jardiance®. ....

United States , Stephan Thalen , Adriaan Voors , Mohamed Eid , Jennifer Forsyth , Eli Lilly , Jeff Emmick , Global Business Communications , Boehringer Ingelheim Pharmaceuticals Inc , Clinical Development Medical Affairs , Boehringer Ingelheim , Boehringer Ingelheim Animal Health In Duluth , Product Development , American Heart Association Late , University Medical Center , Drug Administration , Exchange Commission , Boehringer Ingelheim Corporation , Animal Health , National Readmission Database , Boehringer Ingelheim Fremont Inc , Kansas City Cardiomyopathy Questionnaire , Nature Medicine , American Heart Association , Late Breaking Scientific Sessions , National Readmission ,